翻訳と辞書 |
Fezakinumab
Fezakinumab is a human monoclonal antibody against interleukin-22,〔(【引用サイトリンク】publisher=American Medical Association )〕 designed for the treatment of psoriasis and rheumatoid arthritis.〔page 6; http://www.pfizer.com/files/research/pipeline/2011_0228/pipeline_2011_0228.pdf〕 Wyeth discovered and initially developed the drug, and clinical development continued after that company was acquired by Pfizer. Fezakinumab, in combination with methotrexate, completed a phase II trial in rheumatoid arthritis, 〔http://lmt.projectsinknowledge.com/Activity/index.cfm?showfile=b&jn=2016&sj=2016.05&sc=2016.05.4〕 but data was not released. Development was discontinued in August 2011. == References ==
〔
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Fezakinumab」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|